Drug search by name

Paricalcitol and Hepatobiliary dysfunction

Generic Name: paricalcitol
Dosage Forms: n.a.
Other Brand Names: Zemplar

Result of checking the interaction of drug Paricalcitol and disease Hepatobiliary dysfunction for safety when used together.

Check result:

Paricalcitol <> Hepatobiliary dysfunction

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

Paricalcitol is metabolized by the liver. Parent compound and metabolites are primarily eliminated by in the bile and feces. Paricalcitol metabolites have not been characterized or identified. Metabolic and therapeutic activity of paricalcitol may be altered in patients with hepatic impairment. Therapy with paricalcitol should be administered cautiously in patients with hepatobiliary dysfunction. Clinical monitoring of hepatobiliary function, parathyroid hormone and calcium levels is recommended.

References: